India reports 1,007 Covid-19 cases in 24 hours
Apr 14, 2022, at 03:56 pm
New Delhi/IBNS: India added seven more than 1,000 Covid-19 cases, slightly less than what was reported a day ago, while the toll went up by 26 in the last 24 hours, the Union Health Ministry said on Thursday.
Covid19 vaccine: ICMR recommends booster shot after nine months of 2nd dose
Dec 11, 2021, at 07:03 am
New Delhi/IBNS: The Indian Council of Medical Research (ICMR) has recommended an additional Covid dose after nine months of full vaccination, media reports said.
US approves Pfizer-BioNTech Covid booster for teenagers aged 16 and 17
Dec 10, 2021, at 06:07 am
Washington/IBNS: The United States Food and Drug Administration (FDA) on Thursday authorised the Pfizer-BioNTech Covid booster to include 16- and 17-year-olds, amid growing concern over the Omicron variant.
Centre's nod on booster dose soon, says Karnataka's revenue minister
Nov 28, 2021, at 06:09 am
Bengaluru/IBNS: Karnataka revenue minister R Ashoka said on Saturday the state government has sought the Centre’s approval regarding administering of booster dose against Covid-19.
Data on need for Covid vaccine booster dose by 2022 : Dr Randeep Guleria
Aug 22, 2021, at 02:56 am
Delhi: The need for a third dose or booster shot of the coronavirus vaccine to maintain protection level against the pathogen could be ascertained after more information is available, All India Institute of Medical Science (AIIMS) director Dr Randeep Guleria said today.
Covid19: UK to vaccinate vulnerable population with third dose ahead of winter
Jul 02, 2021, at 12:46 am
London/IBNS: The UK Government is preparing to give a booster shot to those Britons, who have already received two doses of coronavirus vaccine, from September in order to ensure that the protection against new variants of the virus is maintained before winter arrives, according to media reports.
Moderna CEO advocates 3rd vaccine dose to protect people at risk
May 23, 2021, at 09:26 pm
Moscow/Sputnik: Vaccination with a booster shot among as many people as possible is a good way to protect those most at risk against ever-emerging new coronavirus variants, Moderna CEO Stephane Bancel said on Sunday.